STOK Stoke Therapeutics, Inc.

Fundamentals / CIK 0001623526 / USD

Stoke Therapeutics, Inc. reported $28.21M in revenue and a net loss of $243.2M for the trailing twelve months ended September 30, 2026 (up 5.9% year over year), with a -913.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open STOK in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$192.8M$96.41M$0-$113.6MFY 2018 Net Income: -$12.52M2018FY 2019 Net Income: -$32.33M2019FY 2020 Net Income: -$52.24M2020FY 2021 Net Income: -$85.81M2021FY 2022 Revenue: $12.40MFY 2022 Net Income: -$101.1M2022FY 2023 Revenue: $8.78MFY 2023 Net Income: -$104.7M2023FY 2024 Revenue: $36.55MFY 2024 Net Income: -$88.98M2024FY 2025 Revenue: $184.4MFY 2025 Net Income: -$6.88M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $184.4M $36.55M $8.78M $12.40M -- -- -- --
Research & Development $137.9M $89.13M $82.23M $77.84M $54.17M $32.20M $23.76M $8.37M
Selling, General & Admin $67.09M $48.79M -- -- -- -- -- --
Total Operating Expenses $205.0M $137.9M $123.6M $116.8M $86.06M $53.04M $35.68M $12.78M
Operating Income -$20.59M -$101.4M -$114.8M -$104.4M -$86.06M -$53.04M -$35.68M -$12.78M
EBITDA -$18.82M -$99.19M -$112.3M -$102.8M -$85.09M -$52.16M -$35.23M -$12.57M
Interest Income $13.77M $12.66M $9.96M -- -- $744K $3.35M $270K
Interest Expense $9.0K $26K $49K -- -- -- -- --
Income Tax Expense $0 -- -- -- -- -- -- --
Net Income -$6.88M -$88.98M -$104.7M -$101.1M -$85.81M -$52.24M -$32.33M -$12.52M
Basic EPS -$0.12 -$1.65 -$2.38 -$2.60 -$2.34 -$1.56 -$1.80 -$17.65
Diluted EPS -$0.12 -$1.65 -$2.38 -$2.60 -$2.34 -$1.56 -$1.80 -$17.65
Basic Shares Outstanding 59.2M 54.0M 44.0M 38.9M 36.7M 33.5M 18.0M 709.3K
Diluted Shares Outstanding 59.2M 54.0M 44.0M 38.9M 36.7M 33.5M 18.0M 709.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $11.26M $9.32M $6.23M $1.40M $10.63M $13.82M $158.6M $22.61M
Research & Development $59.83M $49.50M $39.67M $41.70M $37.70M $25.86M $32.68M $23.42M
Selling, General & Admin $28.74M $25.25M $19.97M $21.15M $16.03M $15.26M $14.65M --
Total Operating Expenses $88.57M $74.75M $59.65M $62.84M $53.72M $41.12M $47.33M $36.27M
Operating Income -$77.31M -$65.43M -$53.42M -$61.44M -$43.09M -$27.30M $111.2M -$13.65M
EBITDA -$76.86M -$64.97M -$52.98M -$61.03M -$42.65M -$26.85M $111.7M -$13.13M
Interest Income $3.69M $3.52M $3.42M $3.62M $3.47M $3.79M $2.89M $2.97M
Interest Expense $20K $17K $23K $3.0K $3.0K $3.0K $1.0K -$1.0K
Income Before Tax -$73.64M -$61.62M -$50.00M -- -$39.62M -$23.48M $114.2M --
Income Tax Expense $0 $0 $0 $0 -$1.28M $0 $1.28M --
Net Income -$73.64M -$61.62M -$50.00M -$57.93M -$38.35M -$23.48M $112.9M -$10.48M
Basic EPS -$1.08 -$0.93 -$0.79 -- -$0.65 -$0.40 $1.95 --
Diluted EPS -$1.08 -$0.93 -$0.79 -- -$0.65 -$0.40 $1.90 --
Basic Shares Outstanding 68.4M 66.0M 63.1M -- 58.6M 58.4M 57.9M --
Diluted Shares Outstanding 68.4M 66.0M 63.1M -- 58.6M 58.4M 59.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $84.22M $128.0M $191.4M $113.6M $144.9M $287.3M $222.5M $105.4M
Short-Term Investments $200.4M $88.92M $9.95M $116.0M $74.92M $0 -- --
Cash & Short-Term Investments $284.7M $216.9M $201.4M $229.6M $219.8M $287.3M $222.5M $105.4M
Accounts Receivable, Net $5.94M $1.67M -- -- -- -- -- --
Other Current Assets $4.39M $2.30M $2.56M $2.96M $2.22M -- -- --
Total Current Assets $305.7M $232.8M $215.3M $244.1M $229.2M $293.9M $226.0M $106.1M
Property, Plant & Equipment, Net $3.15M $3.91M $5.82M $6.67M $4.14M $2.67M $2.51M $1.19M
Long-Term Investments $106.3M $29.82M -- -- -- -- -- --
Total Non-Current Assets $112.7M $38.80M $13.00M $12.00M $9.65M $4.00M $2.72M $1.40M
Total Assets $418.4M $271.6M $228.3M $256.1M $238.9M $297.9M $228.8M $107.5M
Accounts Payable $4.94M $2.50M $1.70M $766K $2.38M $1.50M $751K $1.07M
Deferred Revenue (Current) $11.90M $18.99M $15.31M $14.88M -- -- -- --
Other Current Liabilities $1.06M $753K $857K $509K $540K $459K $54K --
Total Current Liabilities $57.88M $40.06M $30.82M $31.39M $17.14M $11.43M $4.10M $2.47M
Deferred Revenue (Non-Current) $6.96M -- $33.07M $36.86M -- -- -- --
Other Non-Current Liabilities $1.14M $2.48M $4.88M $2.97M $3.95M -- -- --
Total Non-Current Liabilities $8.10M $2.48M $37.96M $39.82M $3.95M $422K $221K $4.0K
Total Liabilities $65.98M $42.53M $68.78M $71.22M $21.09M $11.85M $4.32M $2.47M
Total Debt (incl. Leases) $4.15M $4.77M $6.83M $5.08M $6.97M $1.15M -- --
Common Stock $5.0K $5.0K $5.0K $4.0K $4.0K $4.0K $3.0K --
Retained Earnings -$497.7M -$490.8M -$401.8M -$297.1M -$196.1M -$110.3M -$58.03M -$25.71M
Accumulated Other Comp. Income $543K -$151K -$24K -$1.18M -$168K -- -- --
Total Stockholders' Equity $352.5M $229.0M $159.6M $184.8M $217.8M $286.1M $224.4M $105.1M
Total Equity $352.5M $229.0M $159.6M $184.8M $217.8M $286.1M $224.4M $105.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $107.3M $110.0M $155.7M $84.22M $83.39M $101.5M $274.8M $128.0M
Short-Term Investments $211.9M $182.8M $187.9M $200.4M $164.9M $146.2M $82.51M $88.92M
Cash & Short-Term Investments $319.2M $292.8M $343.5M $284.7M $248.3M $247.7M $357.3M $216.9M
Accounts Receivable, Net $8.54M $7.18M $4.45M $5.94M $9.25M -- -- $1.67M
Other Current Assets $7.56M $6.31M $6.88M $4.39M $5.54M $6.87M $5.04M $2.30M
Total Current Assets $354.4M $322.5M $366.7M $305.7M $272.4M $270.0M $375.7M $232.8M
Property, Plant & Equipment, Net $8.21M $4.83M $3.40M $3.15M $3.08M $3.34M $3.61M $3.91M
Long-Term Investments $39.60M $61.50M $67.48M $106.3M $80.31M $107.3M $22.99M $29.82M
Total Non-Current Assets $52.27M $71.43M $76.60M $112.7M $87.83M $114.5M $31.15M $38.80M
Total Assets $406.7M $394.0M $443.3M $418.4M $360.3M $384.5M $406.9M $271.6M
Accounts Payable $4.03M $4.79M $6.84M $4.94M $5.87M $4.31M $2.19M $2.50M
Deferred Revenue (Current) $6.36M $8.52M $10.07M $11.90M $5.76M $8.75M $18.16M $18.99M
Other Current Liabilities $1.75M $1.62M $1.50M $1.06M $795K $1.75M $2.07M $753K
Total Current Liabilities $48.98M $41.93M $40.81M $57.88M $41.73M $38.68M $44.69M $40.06M
Deferred Revenue (Non-Current) $4.45M $5.65M $6.60M $6.96M $8.56M $9.63M $10.26M --
Other Non-Current Liabilities $681K $837K $991K $1.14M $1.87M $1.25M $1.87M $2.48M
Total Non-Current Liabilities $5.13M $6.49M $7.59M $8.10M $10.43M $10.89M $12.13M $2.48M
Total Liabilities $54.10M $48.42M $48.40M $65.98M $52.16M $49.56M $56.81M $42.53M
Total Debt (incl. Leases) $1.92M $2.68M $3.42M $4.15M $4.78M $5.28M $5.95M $4.77M
Common Stock $6.0K $6.0K $6.0K $5.0K $5.0K $5.0K $5.0K $5.0K
Retained Earnings -$683.0M -$609.3M -$547.7M -$497.7M -$439.8M -$401.4M -$378.0M -$490.8M
Accumulated Other Comp. Income -$1.05M -$542K -$115K $543K $446K $96K -$104K -$151K
Total Stockholders' Equity $352.6M $345.5M $394.9M $352.5M $308.1M $334.9M $350.1M $229.0M
Total Equity $352.6M $345.5M $394.9M $352.5M $308.1M $334.9M $350.1M $229.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$6.88M -$88.98M -$104.7M -$101.1M -$85.81M -$52.24M -$32.33M -$12.52M
Depreciation & Amortization $1.77M $2.18M $2.47M $1.55M $974K $888K $450K $214K
Stock-Based Compensation $32.24M $27.47M $25.26M $22.85M $16.45M $5.77M $1.92M $240K
Change in Receivables -$4.27M -$50K -- -- -- -- -- --
Operating Cash Flow $45.59M -$86.85M -$81.07M -$31.87M -$66.91M -$42.22M -$31.05M -$10.96M
Capital Expenditure -$670K -$203K -$1.62M -$3.96M -$1.20M -$1.05M -$1.64M -$935K
Free Cash Flow $44.91M -$87.05M -$82.68M -$35.83M -$68.11M -$43.27M -$32.69M -$11.90M
Purchases of Investments -$322.7M -$167.3M $0 -$201.3M -$87.23M -- -- --
Investing Cash Flow -$186.8M -$107.5M $105.9M -$45.88M -$76.43M -$1.05M -$1.63M -$925K
Financing Cash Flow $97.39M $131.1M $53.01M $46.41M $1.28M $108.1M $149.8M $115.6M
Net Change in Cash -$43.84M -$63.23M $77.89M -$31.34M -$142.0M $64.84M $117.1M $103.8M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$73.64M -$61.62M -$50.00M -$57.93M -$38.35M -$23.48M $112.9M -$10.48M
Depreciation & Amortization $455K $458K $439K $405K $442K $446K $477K $526K
Stock-Based Compensation $11.03M $10.80M $8.75M $9.85M $8.04M $7.60M $6.75M $7.14M
Change in Receivables -$1.36M -$2.73M $1.49M $3.31M -$11.33M $5.08M -$1.32M --
Operating Cash Flow -$62.69M -$56.59M -$60.58M -$30.45M -$30.37M -$25.42M $131.8M -$23.19M
Capital Expenditure -$2.85M -$1.98M -$353K -$232K -$132K -$154K -$152K -$42K
Free Cash Flow -$65.54M -$58.56M -$60.94M -$30.69M -$30.50M -$25.58M $131.7M -$23.23M
Purchases of Investments -$58.01M -$36.11M -$9.85M -$98.23M -$23.93M -$181.6M -$19.02M --
Investing Cash Flow -$10.21M $9.02M $50.69M -$61.06M $9.09M -$148.5M $13.63M $819K
Financing Cash Flow $70.16M $1.91M $84.33M $92.34M $3.12M $554K $1.37M $568K
Net Change in Cash -$2.73M -$45.66M $74.44M $826K -$18.15M -$173.3M $146.8M -$21.81M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -11.2% -277.3% -1307.2% -841.2% -- -- -- --
Net Profit Margin -3.7% -243.4% -1192.5% -814.7% -- -- -- --
Return on Equity (ROE) -2.0% -38.9% -65.6% -54.7% -39.4% -18.3% -14.4% -11.9%
Return on Assets (ROA) -1.6% -32.8% -45.9% -39.5% -35.9% -17.5% -14.1% -11.6%
Current Ratio 5.28x 5.81x 6.99x 7.77x 13.37x 25.73x 55.12x 43.03x
Quick Ratio 5.02x 5.46x 6.53x 7.31x 12.83x 25.15x 54.25x 42.72x
Debt to Equity 0.01x 0.02x 0.04x 0.03x 0.03x 0.00x -- --
Revenue Growth (YoY) +404.5% +316.3% -29.2% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -913.1% -809.7% -577.5% -11.2% 13.2% 20.2% 20.0% -277.3%
Net Profit Margin -862.1% -753.6% -529.2% -3.7% 19.7% 26.3% 26.3% -243.4%
Return on Equity (ROE) -69.0% -60.2% -43.0% -2.0% 13.2% 15.7% 14.4% -38.9%
Return on Assets (ROA) -59.8% -52.8% -38.3% -1.6% 11.3% 13.6% 12.4% -32.8%
Current Ratio 7.24x 7.69x 8.99x 5.28x 6.53x 6.98x 8.41x 5.81x
Quick Ratio 6.69x 7.15x 8.53x 5.02x 6.17x 6.40x 8.00x 5.46x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.02x 0.02x 0.02x 0.02x
Revenue Growth (YoY) +5.9% -32.5% -96.1% -93.8% +117.2% +186.0% +3661.1% +707.1%
Operating Income Growth (YoY) -- -- -148.0% -- -- -- -- --
Net Income Growth (YoY) -- -- -144.3% -- -- -- -- --
EPS Growth (YoY) -- -- -140.5% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -146.0% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -146.3% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001623526) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal